当前黄病毒研究对疫苗开发至关重要。
Current Flavivirus Research Important for Vaccine Development.
作者信息
Geerling Elizabeth, Steffen Tara L, Brien James D, Pinto Amelia K
机构信息
Department of Molecular Microbiology and Immunology, Saint Louis University, St Louis, MO 63103, USA.
出版信息
Vaccines (Basel). 2020 Aug 27;8(3):477. doi: 10.3390/vaccines8030477.
Abstract
The Flaviviridae family of RNA viruses includes numerous human disease-causing pathogens that largely are increasing in prevalence due to continual climate change, rising population sizes and improved ease of global travel [...].
摘要
黄病毒科RNA病毒包括众多导致人类疾病的病原体，由于持续的气候变化、人口规模的增加以及全球旅行便利性的提高，这些病原体的流行率在很大程度上正在上升[……]
相似文献
1
Current Flavivirus Research Important for Vaccine Development.当前黄病毒研究对疫苗开发至关重要。
Vaccines (Basel). 2020 Aug 27;8(3):477. doi: 10.3390/vaccines8030477.
2
Virus-Like Particle Systems for Vaccine Development against Viruses in the Flaviviridae Family.用于开发针对黄病毒科病毒疫苗的病毒样颗粒系统
Vaccines (Basel). 2019 Sep 20;7(4):123. doi: 10.3390/vaccines7040123.
3
A New Subclass of Exoribonuclease-Resistant RNA Found in Multiple Genera of .在多个属的. 中发现了一种新的抗外切核酸酶 RNA 亚类
mBio. 2020 Sep 29;11(5):e02352-20. doi: 10.1128/mBio.02352-20.
4
Formalin-inactivated whole virus and recombinant subunit flavivirus vaccines.福尔马林灭活全病毒和重组亚单位黄病毒疫苗。
Adv Virus Res. 2003;61:395-418. doi: 10.1016/s0065-3527(03)61010-9.
5
ICTV Virus Taxonomy Profile: Flaviviridae.国际病毒分类委员会病毒分类概况：黄病毒科。
J Gen Virol. 2017 Jan;98(1):2-3. doi: 10.1099/jgv.0.000672.
6
Current approaches in antiviral drug discovery against the Flaviviridae family.针对黄病毒科的抗病毒药物研发的当前方法。
Curr Pharm Des. 2014;20(21):3428-44. doi: 10.2174/13816128113199990635.
7
Spot the difference-development of a syndrome based protein microarray for specific serological detection of multiple flavivirus infections in travelers.找出差异——基于综合征的蛋白质微阵列的开发，用于旅行者中多种黄病毒感染的特异性血清学检测。
PLoS Negl Trop Dis. 2015 Mar 13;9(3):e0003580. doi: 10.1371/journal.pntd.0003580. eCollection 2015 Mar.
8
The yellow fever 17D vaccine virus as a vector for the expression of foreign proteins: development of new live flavivirus vaccines.黄热病17D疫苗病毒作为表达外源蛋白的载体：新型黄病毒活疫苗的研发
Mem Inst Oswaldo Cruz. 2000;95 Suppl 1:215-23. doi: 10.1590/s0074-02762000000700037.
9
Flavivirus: From Structure to Therapeutics Development.黄病毒：从结构到治疗药物研发
Life (Basel). 2021 Jun 25;11(7):615. doi: 10.3390/life11070615.
10
An updated evolutionary study of Flaviviridae NS3 helicase and NS5 RNA-dependent RNA polymerase reveals novel invariable motifs as potential pharmacological targets.黄病毒科NS3解旋酶和NS5 RNA依赖性RNA聚合酶的最新进化研究揭示了作为潜在药理学靶点的新型保守基序。
Mol Biosyst. 2016 Jun 21;12(7):2080-93. doi: 10.1039/c5mb00706b.
引用本文的文献
1
Dengue and Flavivirus Co-Infections: Challenges in Diagnosis, Treatment, and Disease Management.登革热与黄病毒合并感染：诊断、治疗及疾病管理中的挑战
Int J Mol Sci. 2025 Jul 10;26(14):6609. doi: 10.3390/ijms26146609.
2
Development of nucleic acid-based vaccines against dengue and other mosquito-borne flaviviruses: the past, present, and future.登革热及其他蚊媒黄病毒核酸疫苗的研发：过去、现在与未来。
Front Immunol. 2025 Jan 7;15:1475886. doi: 10.3389/fimmu.2024.1475886. eCollection 2024.
本文引用的文献
1
Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine.抗寨卡病毒 DNA 疫苗的安全性和免疫原性。
N Engl J Med. 2021 Sep 16;385(12):e35. doi: 10.1056/NEJMoa1708120.
2
Severe Multiorgan Failure Following Yellow Fever Vaccination.黄热病疫苗接种后发生的严重多器官功能衰竭。
Vaccines (Basel). 2020 May 26;8(2):249. doi: 10.3390/vaccines8020249.
3
Immunogenicity and Efficacy of a Recombinant Human Adenovirus Type 5 Vaccine against Zika Virus.一种重组人5型腺病毒疫苗针对寨卡病毒的免疫原性和效力
Vaccines (Basel). 2020 Apr 7;8(2):170. doi: 10.3390/vaccines8020170.
4
Using Next Generation Sequencing to Study the Genetic Diversity of Candidate Live Attenuated Zika Vaccines.使用下一代测序技术研究候选减毒活寨卡疫苗的遗传多样性。
Vaccines (Basel). 2020 Apr 3;8(2):161. doi: 10.3390/vaccines8020161.
5
Vaccination with AgBR1 Delays Lethal Mosquito-Borne Zika Virus Infection in Mice.用AgBR1疫苗接种可延缓小鼠因蚊子传播的致命寨卡病毒感染。
Vaccines (Basel). 2020 Mar 25;8(2):145. doi: 10.3390/vaccines8020145.
6
Addition of Partial Envelope Domain II into Envelope Domain III of Dengue Virus Antigen Potentiates the Induction of Virus-Neutralizing Antibodies and Induces Protective Immunity.将登革病毒抗原的部分包膜结构域II添加到包膜结构域III中可增强病毒中和抗体的诱导并诱导保护性免疫。
Vaccines (Basel). 2020 Feb 15;8(1):88. doi: 10.3390/vaccines8010088.
7
Tick-Borne Encephalitis Virus Vaccines Contain Non-Structural Protein 1 Antigen and may Elicit NS1-Specific Antibody Responses in Vaccinated Individuals.蜱传脑炎病毒疫苗含有非结构蛋白1抗原，可能会在接种疫苗的个体中引发针对NS1的特异性抗体反应。
Vaccines (Basel). 2020 Feb 12;8(1):81. doi: 10.3390/vaccines8010081.
8
Efficient Delivery of Dengue Virus Subunit Vaccines to the Skin by Microprojection Arrays.通过微喷射阵列将登革病毒亚单位疫苗高效递送至皮肤
Vaccines (Basel). 2019 Nov 20;7(4):189. doi: 10.3390/vaccines7040189.
9
The Interplay between Dengue Virus and the Human Innate Immune System: A Game of Hide and Seek.登革病毒与人类先天免疫系统之间的相互作用：一场捉迷藏游戏。
Vaccines (Basel). 2019 Oct 10;7(4):145. doi: 10.3390/vaccines7040145.
10
Virus-Like Particle Systems for Vaccine Development against Viruses in the Flaviviridae Family.用于开发针对黄病毒科病毒疫苗的病毒样颗粒系统
Vaccines (Basel). 2019 Sep 20;7(4):123. doi: 10.3390/vaccines7040123.
Zotero 插件